AU2212699A - Use of 8-cl-camp in prevention of restenosis of arterial walls - Google Patents

Use of 8-cl-camp in prevention of restenosis of arterial walls

Info

Publication number
AU2212699A
AU2212699A AU22126/99A AU2212699A AU2212699A AU 2212699 A AU2212699 A AU 2212699A AU 22126/99 A AU22126/99 A AU 22126/99A AU 2212699 A AU2212699 A AU 2212699A AU 2212699 A AU2212699 A AU 2212699A
Authority
AU
Australia
Prior art keywords
restenosis
camp
prevention
arterial walls
arterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22126/99A
Inventor
Ciro Indolfi
Giampaolo Tortora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Pharmaceuticals International Inc USA
Original Assignee
ICN Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICN Pharmaceuticals Inc filed Critical ICN Pharmaceuticals Inc
Publication of AU2212699A publication Critical patent/AU2212699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22126/99A 1998-01-15 1999-01-13 Use of 8-cl-camp in prevention of restenosis of arterial walls Abandoned AU2212699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7108598P 1998-01-15 1998-01-15
US60071085 1998-01-15
PCT/US1999/000143 WO1999036074A1 (en) 1998-01-15 1999-01-13 Use of 8-cl-camp in prevention of restenosis of arterial walls

Publications (1)

Publication Number Publication Date
AU2212699A true AU2212699A (en) 1999-08-02

Family

ID=22099148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22126/99A Abandoned AU2212699A (en) 1998-01-15 1999-01-13 Use of 8-cl-camp in prevention of restenosis of arterial walls

Country Status (2)

Country Link
AU (1) AU2212699A (en)
WO (1) WO1999036074A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN114404427A (en) 2014-02-13 2022-04-29 配体药物公司 Prodrug compound and use thereof
US9994600B2 (en) 2014-07-02 2018-06-12 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
EP3737676B1 (en) 2018-01-09 2024-03-06 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861873A (en) * 1987-12-21 1989-08-29 Nucleic Acid Research Institute 8-Chloroadenosine 3', 5'-cyclic monophosphate preparations
JPH04501254A (en) * 1988-05-23 1992-03-05 アメリカ合衆国 Cyclic AMP derivatives as cancer therapeutic agents
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
AU4226693A (en) * 1992-05-01 1993-11-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Phosphorothioate derivatives of cyclic AMP analogues
US5567828A (en) * 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side

Also Published As

Publication number Publication date
WO1999036074A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
IL147296A0 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents
AU2480499A (en) Calcification-resistant medical articles
AU4061900A (en) Transition metal bleaching agents
HUP0202477A3 (en) Use of phthalazine derivatives
AU1129400A (en) Improved user customizable knee brace
AU1621499A (en) Thrombus macerator catheter
AU5100599A (en) Egf-genistein for prevention of restenosis
AU5056300A (en) Devices and compounds for treating arterial restenosis
AU6726100A (en) Antiandrogen agents
AU1969800A (en) Combination of active agents
AU2001260834A1 (en) The treatment of herpes
AU1889599A (en) Disintegrating agent
AU2212699A (en) Use of 8-cl-camp in prevention of restenosis of arterial walls
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB9910377D0 (en) Tissue engineering
GB2336779B (en) External Catheter
AU5762899A (en) Caspase inhibitor
AU6102899A (en) Production and use of antimicrobial agents
PL350963A1 (en) Use of arylalkanoylpyridazines
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU5400200A (en) Bleaching and disinfecting agents
GB9809889D0 (en) Prevention of restenosis
AU1548801A (en) Melanogenesis inhibitor
PL346528A1 (en) Treatment of depression
AUPP942599A0 (en) Antiviral agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase